ATE390149T1 - Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium - Google Patents

Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium

Info

Publication number
ATE390149T1
ATE390149T1 AT03792412T AT03792412T ATE390149T1 AT E390149 T1 ATE390149 T1 AT E390149T1 AT 03792412 T AT03792412 T AT 03792412T AT 03792412 T AT03792412 T AT 03792412T AT E390149 T1 ATE390149 T1 AT E390149T1
Authority
AT
Austria
Prior art keywords
preparation containing
diclofenac sodium
gel preparation
emulsion gel
containing diclofenac
Prior art date
Application number
AT03792412T
Other languages
English (en)
Inventor
Michel Steiger
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31896841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE390149(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Application granted granted Critical
Publication of ATE390149T1 publication Critical patent/ATE390149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT03792412T 2002-08-22 2003-08-21 Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium ATE390149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02018772 2002-08-22

Publications (1)

Publication Number Publication Date
ATE390149T1 true ATE390149T1 (de) 2008-04-15

Family

ID=31896841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03792412T ATE390149T1 (de) 2002-08-22 2003-08-21 Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium

Country Status (16)

Country Link
US (3) US7732489B2 (de)
EP (1) EP1536836B1 (de)
AR (1) AR041021A1 (de)
AT (1) ATE390149T1 (de)
AU (1) AU2003264086B2 (de)
BR (1) BR0313701A (de)
CA (1) CA2496469C (de)
DE (1) DE60319997T2 (de)
DK (1) DK1536836T3 (de)
ES (1) ES2300645T3 (de)
MX (1) MXPA05002077A (de)
PE (1) PE20040321A1 (de)
PT (1) PT1536836E (de)
SI (1) SI1536836T1 (de)
TW (1) TWI316857B (de)
WO (1) WO2004017998A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1588697A1 (de) * 2004-04-16 2005-10-26 Kurt H. Prof. Dr. Bauer Emulsiongel für die topische Anwendung von Arzneimittel
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
EP1919444A2 (de) * 2005-04-27 2008-05-14 Avocet Polymer Technologies, Inc. Zusammensetzungen auf polyethylenglykolbasis für die topische behandlung einer geschlossenen wunde mit therapeutischen pharmazeutika
JP2010502764A (ja) 2006-09-11 2010-01-28 バイオマス リミテッド テルル含有化合物の局所製剤
RU2463038C2 (ru) * 2006-10-17 2012-10-10 Нуво Рисерч Инк. Диклофенаковый гель
GB0704846D0 (en) * 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
DE102007034976A1 (de) 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren
EP2055298A1 (de) * 2007-10-30 2009-05-06 Novartis AG Topische Zusammensetzung
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
US20100100060A1 (en) * 2008-10-17 2010-04-22 Novartis Ag Applicator for pharmaceutical product and method of using same
DE102009008094A1 (de) * 2009-02-09 2010-08-19 Barnikol-Keuten, Doris, Dr. In situ Haft-Gelbildende Zubereitungen, insbesondere zur topischen Anwendung auf befeuchtete Haut/Schleimhaut
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
EP2416759A2 (de) 2009-04-08 2012-02-15 Cadila Healthcare Limited Stabile pharmazeutische diclofenac-zusammensetzungen
PL2512446T3 (pl) * 2009-12-16 2015-08-31 Shasun Pharmaceuticals Ltd Kompozycja transdermalnego hydrożelu z deksibuprofenem
US9713590B2 (en) 2011-07-28 2017-07-25 Cadila Healthcare Limited Method for treatment of pain and inflammation
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
JP6259454B2 (ja) 2012-07-12 2018-01-10 フェリング ベスローテン フェンノートシャップ ジクロフェナク製剤
RU2702898C2 (ru) 2014-09-10 2019-10-14 Гск Консьюмер Хелткер С.А. Композиции диклофенака натрия для местного применения
GB201502845D0 (en) * 2015-02-20 2015-04-08 Futura Medical Dev Ltd Topical pharmaceutical formulation
JP6598619B2 (ja) * 2015-09-28 2019-10-30 株式会社ポーラファルマ 物性で特定される皮膚外用剤
FR3064495B1 (fr) * 2017-03-31 2021-04-02 Total Marketing Services Composition a base d'uree pour le traitement des gaz d'echappement
EP4408393A1 (de) 2021-10-01 2024-08-07 Nutrition & Biosciences USA 1, LLC Hydrokolloidzusammensetzungen zur topischen anwendung
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (de) 1982-10-07 1986-05-15
WO1992007561A1 (fr) 1990-10-30 1992-05-14 Ss Pharmaceutical Co., Ltd. Preparation d'un gel anti-inflammatoire et analgesique
EP0592569A1 (de) * 1991-07-03 1994-04-20 Sano Corporation Zusammensetzung und verfahren zur transdermalen verabreichung von diclofenac
US5399342A (en) * 1993-02-03 1995-03-21 Dow Corning Corporation Cosmetics with enhanced durability
EP0879597A4 (de) * 1996-02-07 2001-01-31 Tsumura & Co Transparente wässrige lösung von natrium diclofenac und arzneimittel unter deren verwendung
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
TWI290464B (en) 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition

Also Published As

Publication number Publication date
AU2003264086A1 (en) 2004-03-11
AR041021A1 (es) 2005-04-27
EP1536836A2 (de) 2005-06-08
DK1536836T3 (da) 2008-07-21
SI1536836T1 (sl) 2008-08-31
EP1536836B1 (de) 2008-03-26
WO2004017998A2 (en) 2004-03-04
US8557870B2 (en) 2013-10-15
BR0313701A (pt) 2005-06-28
AU2003264086B2 (en) 2007-01-04
TWI316857B (en) 2009-11-11
CA2496469C (en) 2011-07-05
US8716340B2 (en) 2014-05-06
US20140045942A1 (en) 2014-02-13
US20100234462A1 (en) 2010-09-16
MXPA05002077A (es) 2005-06-08
US7732489B2 (en) 2010-06-08
DE60319997T2 (de) 2009-04-30
TW200409646A (en) 2004-06-16
ES2300645T3 (es) 2008-06-16
PT1536836E (pt) 2008-05-09
DE60319997D1 (de) 2008-05-08
PE20040321A1 (es) 2004-07-15
WO2004017998A3 (en) 2004-04-01
CA2496469A1 (en) 2004-03-04
US20050239894A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
ATE390149T1 (de) Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium
NO343756B1 (no) Gelformulering med oksybutynin for utildekket topisk anvendelse
DE60324099D1 (de) Arzneistoffhaltiger tampon
NO20052914D0 (no) Terapeutiske forbindelser
PT1501534E (pt) Formulacoes farmaceuticas
DE60324178D1 (de) THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN
FIU20020500U0 (fi) Tamsulosiinia sisältävät farmaseuttiset pelletit
FR2842417B1 (fr) Composition cosmetique
DK3536344T3 (da) Superfin formoterolformulering
DE50301661D1 (de) Darreichungsform von Ibuprofen-Natrium
NO20052952D0 (no) Farmasoytisk sammensetning som innbefatter mikropartikler
HK1089094A1 (en) Pharmaceutical formulation comprising levothyroxine sodium
DE60318132D1 (de) Haarwaschmittel
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
DE60329874D1 (de) Haarwaschmittel
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan
DE60316102D1 (de) Einkomponentige Organopolysiloxangelzusammensetzung
NO20050689L (no) Terapeutisk anvendelse
DE60319547D1 (de) Haarwaschmittel
DE602004022688D1 (de) Reflektierender film
NO20005758D0 (no) Farmasöytisk preparat som inneholder levotyroksin-natrium
DE60335019D1 (de) Topische hautpräparate
DE60326998D1 (de) Orale zubereitung
NO20043576L (no) Pharmaceutical formulation comprising melatonin
AU2003269266A1 (en) Transparent gel composition, for the administration of diclofenac sodium through the skin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1536836

Country of ref document: EP